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Abstract
Mice with the C3H background show greater behavioral propensity for
schizophrenia, including lower prepulse inhibition (PPI), than C57BL/6
(B6) mice. To characterize as-yet-unknown pathophysiologies of
schizophrenia, we undertook proteomics analysis of the brain in these
strains, and detected elevated levels of Mpst, a hydrogen sulfide (H2S)/
polysulfide-producing enzyme, and greater sulfide deposition in C3H
than B6mice.Mpst-deficient mice exhibited improved PPI with reduced
storage sulfide levels, while Mpst-transgenic (Tg) mice showed deterio-
rated PPI, suggesting that “sulfide stress” may be linked to PPI impair-
ment. Analysis of human samples demonstrated that the H2S/
polysulfides production system is upregulated in schizophrenia. Mecha-
nistically, the Mpst-Tg brain revealed dampened energy metabolism,
while maternal immune activation model mice showed upregulation of
genes for H2S/polysulfides production along with typical antioxidative
genes, partly via epigenetic modifications. These results suggest that
inflammatory/oxidative insults in early brain development result in
upregulated H2S/polysulfides production as an antioxidative response,
which in turn cause deficits in bioenergetic processes. Collectively, this
study presents a novel aspect of the neurodevelopmental theory for
schizophrenia, unraveling a role of excess H2S/polysulfides production.
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Introduction
Schizophrenia is a severe mental illness featuring three major
symptomatic domains: positive symptoms (hallucinations, delu-
sions, etc.), negative symptoms (affective flattening, avolition,
etc.), and cognitive deficits (disorganized thought, etc.) (American
Psychiatric Association, 2013). This illness exhibits a life-time
prevalence of approximately one percent worldwide. Repeated
relapses of psychotic symptoms often lead to a deterioration of
brain function, and eventually to end-stage illness in some cases,
characterized by persistent symptoms and profound functional
disabilities (Lewis & Lieberman, 2000). Though causal mecha-
nisms are elusive, accumulating lines of evidence have shown
abnormalities in early neurodevelopment processes, stemmed from
genetic aberrations and environmental factors, such as maternal
immune activation, for the etiopathogenesis of schizophrenia (neu-
rodevelopmental hypothesis) (Knuesel et al, 2014; Estes & McAllis-
ter, 2016; Birnbaum & Weinberger, 2017). And for symptomatic
treatments, drugs targeting dopaminergic systems are predomi-
nantly used (Murray et al, 2017). However, because currently
available therapeutics has limitations in terms of efficacies and
adverse effects, a new paradigm is needed for the development of
novel drugs.
Here, we hypothesize that examination of the traits and associ-
ated molecular underpinnings in inbred mouse strains could poten-
tially identify as-yet-unknown pathophysiologies of schizophrenia.
Pursuing this hypothesis, we have already reported that across 4
strains of mice, C57BL/6N (B6) mice exhibited the highest prepulse
inhibition (PPI) scores while C3H/HeN (C3H) the lowest (Watanabe
et al, 2007). PPI is the normal suppression of a startle response
when a low-intensity stimulus immediately precedes an unexpected
stronger startling stimulus. As a reproducible phenotypic marker,
impaired PPI reflects sensorimotor gating deficits, and is typically
regarded as an endophenotype for schizophrenia (Braff et al, 2001;
Roussos et al, 2016).
To explore the molecular signature underlying the behavioral
differences between B6 and C3H, we performed proteomic
analyses, using 2D-DIGE (two-dimensional difference gel
electrophoresis) and MALDI-TOF MS (matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry). This
screening step revealed an increase in the levels of a hydrogen
sulfide (H2S)- and polysulfides- (H2S/polysulfides)-producing
enzyme, Mpst (3-mercaptopyruvate sulfurtransferase; also
known as 3MST) (Appendix Fig S1), in C3H mice compared to
B6 animals. Then, we comprehensively assessed the biological
possibility of the novel theory of “excessive H2S/polysulfides
production” in schizophrenia, and pursued the mechanism
underlying the functional consequence and causative origin of
this phenomenon.
Results
Proteomic analyses of brain and splenic lymphocytes from B6
and C3H mice identified Mpst
We performed proteomic analyses using brain and lymphocyte
preparations from B6 and C3H mice to detect a homologous
biomarker in the peripheral blood of schizophrenia patients. As
shown in Fig 1A and B, and Appendix Tables S1 and S2, of the
1,093 spots identified from the brain using 2D-DIGE, 43 showed
significant differences in expression between B6 and C3H animals,
with our criteria of a fold change > 1.2 and P < 0.05. Of the 1,400
spots detected from the lymphocyte preparations, 131 showed
significant differences in expression between B6 and C3H mice.
Sixteen of these differentially expressed protein spots showed
consistent change trends between the tissues from the two mouse
strains (Appendix Table S2).
We successfully identified the molecular entities of nine of
these protein spots, by peptide mass fingerprinting (PMF), and
found five different proteins: heat shock 70 kDa protein 9
(mortalin, Hspa9), nucleophosmin/nucleoplasmin (Npm1), Mpst,
peroxiredoxin 6 (Prdx6), and nucleoside diphosphate kinase B
(Nme2) (Appendix Tables S3 and S4). The proteins Hspa9,
Npm1, Prdx6, and Nme2 appeared as paired spots at different
isoelectric points (pI) (Fig 1C, D, F and G). Sequencing of the
genes encoding these proteins revealed that each gene harbored
single-nucleotide polymorphisms (SNPs) or insertion/deletion
polymorphisms, which altered the amino acid sequences between
the two mouse strains (Appendix Table S5 and Appendix Fig S2).
The theoretical pI and molecular mass values calculated based on
DNA sequences and possible posttranslational modifications were
consistent with the observed spot profiles of these proteins in 2D
gels, and were confirmed by 2D Western blotting (Fig 2A–J). By
using 2D-DIGE, Mpst appeared as a single spot that was
expressed in only C3H mice (Fig 1E). Two-dimensional Western
blotting confirmed this spot for C3H animals (Fig 2F) and
detected a faint spot for B6 mice at a different pI from the spot
observed for C3H mice (Fig 2E). Sequencing of the Mpst gene
revealed a Asp102Gly polymorphism (Appendix Table S5 and
Appendix Fig S2), which can explain the differential mobility in
the 2D gel between the two mouse strains. The Mpst protein
catalyzes the transfer of a sulfur ion from 3-mercaptopyruvate to
cyanide or other thiol compounds (Szabo, 2007; Kimura, 2015;
Wallace & Wang, 2015), and this reaction produces H2S/polysul-
fides and detoxifies cyanide (Appendix Fig S1). The Asp102Gly
polymorphism is predicted to have little effect (“benign”) by the
PolyPhen-2 algorithm (http://genetics.bwh.harvard.edu/pph2/).
Indeed, the functional assay conducted by preparing Asp102 and
Gly102 Mpst constructs showed no significant differences in enzy-
matic activity between the variants (Appendix Fig S3 and
Appendix Table S6).
The Mpst spot was the only protein to show differential expres-
sion, exhibiting lower expression in B6 mice than in C3H mice. The
protein expression levels for Mpst were confirmed by standard
Western blot analyses of B6 and C3H mice using both brains and
splenic lymphocytes: significantly higher expression of Mpst was
observed in the frontal cortex of the C3H mouse brain than in that
of the B6 brain using both anti-Mpst N-terminus (Mpst-N, P = 0.03,
Fig EV1A) and anti-Mpst C-terminus (Mpst-C, P = 0.02, Fig 3A)
antibodies, though only a marginally increased expression of Mpst
was observed in C3H mice in splenic lymphocytes (Mpst-N,
P = 0.25; Mpst-C, P = 0.11) (Figs 3B and EV1B). Because of the
nonsignificant differences in protein expression levels in lympho-
cytes between the two strains, we hereafter focused on mainly brain
tissues.
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Sulfide content in the brain was higher in C3H than in B6 mice
Next, we examined whether upregulation of Mpst caused elevated
deposition of the free form of sulfur, i.e., H2S, and/or stored
sulfur, i.e., acid-labile sulfur and bound sulfane sulfur, which
includes H2Sn (n = 2: persulfide, n > 2: polysulfides) and persulfu-
rated-cysteine, -glutathione (GSH), and -proteins (Appendix Fig
S4) (Kimura, 2015). H2S2 and H2S3 were recently shown to be
generated from 3-mercaptopyruvate by Mpst and to be present in
the brain (Kimura et al, 2013, 2015, 2017; Koike et al, 2017; Naga-
hara et al, 2018). Acid-labile sulfur is mainly found in an iron–
sulfur complex attached to enzymes belonging to the respiratory
chain including aconitase (Ishigami et al, 2009) (Appendix Fig S4).
This complex releases H2S under acidic conditions, but not under
physiological conditions. Bound sulfane sulfur releases H2S under
reducing conditions (Appendix Fig S4) (Ishigami et al, 2009). As
shown in Fig 3D and E, the H2S and acid-labile sulfur content was
unchanged between the two mouse strains, but the bound sulfane
sulfur content was markedly elevated in the C3H brain compared
to the B6 brain (Fig 3F), suggesting an increase in the levels of
H2Sn and per- and poly-sulfurated molecules. The endogenous H2S
produced by enzymes may be readily oxidized to H2Sn and incor-
porated into bound sulfane sulfur (Shibuya et al, 2009; Kimura
et al, 2015).
Mpst deficiency or overexpression, and external sulfides affect
mouse behaviors
Since Mpst was observed to be overexpressed in C3H when
compared to that in B6, it is important to determine whether Mpst
plays a role in the distinct PPI levels between B6 and C3H. To assess
the role of Mpst, we generated Mpst knockout (KO) mice in the C3H
background (Appendix Fig S5), and Mpst-transgenic (Tg) mice in
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Figure 1. Differential proteomic analysis of brain and lymphocyte tissues from B6 and C3H mice using 2D-DIGE.
A, B Results of 2D-DIGE on frontal cortex tissue (A) and lymphocytes (B). Green and red rings denote spots showing significantly increased expression in B6 and C3H
mice, respectively.
C–G Merged images of Cy3 (green) and Cy5 (red): green and red spots represent significantly increased expression of the corresponding protein isoforms in B6 and C3H
mice, respectively. Nine (spot nos. 1, 2, 3, 4, 5, 10, 11, 12 and 13) out of the 16 spots were successfully identified as mortalin (Hspa9) (C), nucleophosmin (Npm1) (D),
mercaptopyruvate sulfurtransferase (Mpst) (E), peroxiredoxin 6 (Prdx6) (F) and nucleoside diphosphate kinase B (Nme2) (G).
Data information: Significance for differential expression between B6 and C3H was defined as P value of < 0.05 (unpaired two-tailed t-test) and fold change > 1.2. Yellow
numbers indicate the 16 spots that showed consistent alterations between brain and lymphocyte samples from the two mouse strains.
Source data are available online for this figure.
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elevated PPI at a prepulse level of 78 dB compared to their wild-type
(WT) littermates (Fig 4A). Interestingly, C3H inbred mice exhibited
an enhanced acoustic startle response (ASR) compared to B6
(Fig 4B), which has been previously reported in schizophrenic
model mice (Egashira et al, 2005; Duncan et al, 2006). Mpst-KO
mice in the C3H background showed diminished ASR relative to
their WT littermates (Fig 4C). In contrast, the Mpst-Tg mice exhib-
ited decreased PPI at prepulse levels of 78 dB and 82 dB (Fig 4D)
and magnified ASR compared to the non-Tg littermates (Fig 4E).
These results indicate that upregulation of the Mpst causes
schizophrenia-related impaired PPI and exaggerated ASR.
Regarding the sulfide levels in the brain, H2S levels were
unaltered by the change in copy number of Mpst (Fig 4F and
G), and the levels of acid-labile sulfur were slightly decreased in
the Mpst-KO mice compared to the WT littermates (Fig 4H).
Notably, the Mpst-KO mice showed a dramatic decrease in
bound sulfane sulfur levels compared to the WT mice (Fig 4I).
These results indicate that when the level of Mpst is decreased,
sulfide deposition in the brain is reduced. The Mpst-Tg mice did
not show any differences in the levels of both free and stored
forms of sulfur (Fig 4G, J and K), probably because the magni-
tude of transgene expression was not sufficiently large
(Appendix Fig S6) for the detection of distinct levels of sulfides
in our assay system.
Next, we examined whether external administration of the H2S-
producing agent, NaHS, can elicit an impaired PPI. Chronic injec-
tions of NaHS decreased the PPI of C3H mice, although that of B6
mice was unchanged (Fig EV2). B6 mice may be relatively resistant
to excess H2S and polysulfides (also see Fig 4K).
Expression of the H2S synthesis system is upregulated
in schizophrenia
The results thus far demonstrated that upregulation of Mpst and
concomitant accumulation of sulfides in the brain possibly causes
the impairment of PPI, a representative biological trait of
schizophrenia. There are two other well-known enzymes, namely,
Cbs/CBS (cystathionine-beta-synthase) and Cth/CTH (cystathionine
gamma-lyase), that are also involved in the production of H2S
(Appendix Fig S1) (Szabo, 2007; Kimura, 2015; Wallace & Wang,
2015). Real-time quantitative PCR (RT–qPCR) analyses revealed that
the levels of the Mpst and Cth mRNAs increased in C3H mouse
brains (Fig 3C). The absolute expression levels of the three genes in














































Figure 2. Identified proteins visualized by 2D Western blotting.
A–J Whole protein extracts from brain tissue of B6 (A, E, G, I). Whole protein extracts from brain tissue of C3H (B, F, H, J). Whole protein extracts from lymphocytes of B6
(C) and C3H (D). Npm3 expression levels were low in the brain (C, D). Hspa9 (mortalin) (A, B), Npm1 (nucleophosmin) (C, D), Mpst (mercaptopyruvate
sulfurtransferase) (Mpst) (E, F), Prdx6 (peroxiredoxin 6) (G, H) and Nme2 (nucleoside diphosphate kinase B) (I, J) were detected by 2D Western blotting using the
corresponding antibodies and chemiluminescence (red). The chemiluminescent signal of Nme2 was visualized by the LAS 3000 chemiluminescence image analyzer
and the other signals were visualized by a Typhoon 9400.
Data information: White crosses (+) indicate landmark spots. Spot numbers (indicated by arrows) correspond to the spot numbers in Fig 1. Yellow arrowheads (G, H)
indicate the overoxidized form of Prdx6.
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Mpst ~ Cbs > Cth (Fig EV3). Therefore, the higher sulfide levels in
C3H than in B6 brains mainly stemmed from differential Mpst
expressions between the two strains. Interestingly, the expression
levels of the differentially expressed Mpst and Cth were positively
correlated with each other (Fig 5A), indicating concerted operation
of the H2S-producing system.
In human postmortem brains [Brodmann area (BA) 8, frontal
cortex] (1st sample set) (Appendix Table S7), RT–qPCR analyses
revealed increased expressions of MPST and CBS in subjects with
schizophrenia (Fig 6A and B), with no change in CTH mRNA
levels (Fig 6C). The absolute expression levels of the three genes
in the human brain followed the trend CBS > CTH > MPST
(Fig EV3), suggesting a relatively strong role of CBS in the regula-
tion of the total sulfide levels in the human brain. The expression
levels of differentially expressed CBS and MPST were well corre-






















































































































































































Figure 3. Expression of Mpst/Mpst and genes encoding the other H2S-producing enzymes and profile of H2S metabolic states in mice.
A, B Mpst protein levels in the brain and lymphocytes from B6 and C3H mice were quantified by standard Western blotting with anti-C-terminal Mpst antibodies (for
anti-N-terminal Mpst antibodies, see Fig EV1). The expression levels of Mpst were normalized using a-tubulin. Bar graphs show the mean expression levels of Mpst
in brain (A) and lymphocyte (B) tissues.
C Transcript expression levels of genes encoding three H2S-producing enzymes in the frontal cortex of B6 (n = 15) and C3H mice (n = 14). The values represent the
mean  SEM.
D H2S content in the frontal cortex of B6 (n = 8) and C3H mice (n = 8). The values are relative to those of B6 and represent mean  SEM.
E Levels of labile sulfur in the frontal cortex of B6 (n = 10) and C3H mice (n = 10). The values are relative to those of B6 and represent mean  SEM.
F Levels of bound sulfane sulfur in the frontal cortex of B6 (n = 10) and C3H mice (n = 10). The values are relative to those of B6 and represent mean  SEM.
Data information: P values were calculated using unpaired two-tailed t-test.
Source data are available online for this figure.
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samples (Fig 5B). As in the case of C3H mice, H2S/polysulfides
production is thought to be upregulated by coordinated leveraging
of multiple genes for H2S/polysulfides synthesis in the schizophre-
nia brain samples.
To verify the idea of upregulated H2S/polysulfides production
state in schizophrenia, we examined a different postmortem
brain sample set (BA17) (2nd sample set) (Ohnishi et al, 2019)
(Appendix Table S8) and evaluated phenotypic features of
schizophrenia that are associated with elevated H2S production
system. In this sample set, the MPST protein expression levels
were higher in the schizophrenia than in the control groups
(Fig 7A). Interestingly, the MPST levels in schizophrenia were
positively correlated with symptom severity scores (a sum of
positive symptom score, negative symptom score, and general
score) at 3 months prior to the death rated by using the Diag-
nostic Instrument for Brain Studies (DIBS) (Ohnishi et al, 2019)
(Fig 7B). The results suggest that patients with schizophrenia
under “sulfide stress” manifest relatively severe psychotic symp-
toms. Here it was difficult to precisely measure H2S/polysulfides
levels in human postmortem brains, because for an accurate
measurement, samples should have been quickly removed and
frozen immediately after death.
We also examined reprogrammed neuronal lineage cells from
patients with schizophrenia. Neurospheres are composed of free-
floating clusters of neural stem or progenitor cells, differentiated
from induced pluripotent stem cells (iPSCs) (Maekawa et al,
2015; Toyoshima et al, 2016). iPSCs-derived neurospheres from
schizophrenia patients carrying 22q11.2 micro-deletions (Fig 6D)
(Bundo et al, 2014; Maekawa et al, 2015; Toyoshima et al, 2016)
showed a significant increase in CBS mRNA compared to those
derived from control subjects (Fig 6E). Absolute expression levels
of CBS are much higher in early developmental cells, such as
iPSCs and iPSCs-derived neurospheres, than in terminally dif-
ferentiated cells (postmortem brain cells, hair follicles, peripheral
blood cells (PBCs), and mouse brain) (Fig EV3). The results indi-
cate that the H2S production system might be already elevated
from the early neurodevelopmental stage in schizophrenia, which
is associated with “neurodevelopmental theory” (Rapoport et al,
2012; Birnbaum & Weinberger, 2017).
We next addressed whether H2S/polysulfides generation could
be a biomarker of schizophrenia. The absolute transcript expres-
sion levels of the three genes for H2S/polysulfides production in
PBCs were all very low, but MPST exhibited the highest expres-
sion levels (Fig EV3). However, the MPST levels in PBCs exhib-
ited no significant changes between subjects with schizophrenia
and control (Fig 6F, Appendix Table S9), and plasma MPST
protein levels were also unchanged between the two groups
(Fig 6G and Appendix Table S9). These results seem to corre-
spond to the mouse data that in mouse lymphocytes Mpst expres-
sion levels were not different between B6 and C3H, and suggest
that it would be difficult to identify a biomarker from peripheral
blood. The large proportion of Mpst protein in blood sample
exists in red blood cells (RBCs) (Włodek & Ostrowski, 1982).
Because RBCs do not have nuclei, the levels of Mpst in plasma
may not be affected by differential gene expression. Then, we
examined hair follicles as a source of biomarker genes (n = 166
for control and n = 149 for schizophrenia) (Maekawa et al,
2015). The MPST was the only substantially expressed transcript
among the three genes for H2S synthesis in this mini-organ
(Figs 6H and EV3) (Maekawa et al, 2019), and MPST mRNA
expression was increased in subjects with schizophrenia (Fig 6I,
Appendix Table S10). None of the confounding factors, such as
age at examination, BMI (body mass index), anti-psychotic drug
dose, age of onset of schizophrenia, duration of the illness, and
smoking, were significantly correlated with MPST mRNA expres-
sion in scalp hair follicles (Appendix Fig S7). Receiver operating
characteristics (ROC) curve analysis determined an optimal cut-off
level of 0.876 based on the maximum Youden index. With this
cut-off level for the MPST/GAPDH mRNA ratio, the sensitivity
and specificity were 73.6 and 47.2%, respectively (area under the
curve = 0.602) (Fig 7C). The results suggest that the subset of
schizophrenia with “sulfide stress” pathophysiology could be
identified using this surrogate marker.
Excess H2S/polysulfides production elicits dampened expression
of genes for energy metabolism, and impairs mitochondrial
energy metabolism and diminishes spine density
To identify potential convergent pathways relevant for functional
impairments elicited by excessive H2S/polysulfides production in
the brain, we performed RNA-seq analyses using Mpst-KO and Tg
mice. Upon disruption of Mpst expression in the frontal cortex, a
total of 480 genes were significantly dysregulated (239 upregu-
lated and 241 downregulated) in the KO mice compared to the
WT littermates (P < 0.05) (Fig 8A and Appendix Table S11). Gene
ontology analysis revealed that the dysregulated genes were
mainly enriched in biological processes involved in mRNA splic-
ing and processing (Appendix Table S12). Transcriptomic analysis
of the frontal cortex revealed significant dysregulation of 1,136
genes (519 upregulated and 617 downregulated) in the Mpst-Tg
mice compared to the non-Tg littermates (P < 0.05) (Fig 8B,
Appendix Table S13). Interestingly, the dysregulated genes in the
Mpst-Tg mice were significantly enriched in the glutamatergic
synaptic transmission and synaptic signaling-related ontology
terms, along with the cellular metabolic processes (Fig 8C and
Appendix Table S12). The roles of synaptic dysregulation and
glutamatergic signaling impairments in the pathogenesis of
schizophrenia are well-known (Uno & Coyle, 2019). Interestingly,
we have also previously showed that deficits in Fabp7, a critical
gene for regulating PPI, affect neurogenesis, NMDA signaling
(Watanabe et al, 2007), and glial cell integrity (Ebrahimi et al,
2016), thus suggesting that genetic network for the PPI endophe-
notype overlaps with that of neurodevelopment and synaptic
properties. In addition, Ingenuity Pathway AnalysisTM demon-
strated significant enrichment of molecular pathways, e.g., glycol-
ysis I, TCA (tricarboxylic acid) cycle II, and dopamine-DARPP32
feedback in cAMP signaling, for the downregulated genes
(P < 0.05) (Fig 8D and Appendix Table S14). This evidence is
consistent with energy metabolism dysfunction (Zuccoli et al,
2017; Sullivan et al, 2019) and the involvement of deficits in
DARP32 systems in the pathogenesis of schizophrenia (Kunii
et al, 2014; Wang et al, 2017; Zuccoli et al, 2017).
We specifically examined the expression levels of Pvalb,
because impairments of parvalbumin (Pvalb, PV)-containing inhi-
bitory GABA (c-aminobutyric acid) neurons in the dorsolateral
prefrontal cortex is a well-recognized finding in schizophrenia
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Figure 4. Mouse behaviors and sulfide deposition in Mpst knockout (KO) and transgenic (Tg) mice.
A Prepulse inhibition (PPI) levels (%) of C3H wild-type littermates (n = 17) and Mpst-KO C3H (n = 17) mice. The X-axis shows prepulse levels. The pulse sound level
was 115 dB.
B Acoustic startle response (ASR) levels of inbred B6 (n = 12) and C3H (n = 12) mice. The unit is arbitrary. The X-axis shows pulse sound levels.
C ASR levels of C3H wild-type littermates (n = 17) and Mpst-KO C3H mice (n = 17). The unit is arbitrary. The X-axis shows pulse sound levels.
D PPI levels of B6 wild-type littermates (n = 17) and Mpst-Tg B6 mice (n = 19). The X-axis shows prepulse levels. The pulse sound level was 115 dB.
E ASR levels of B6 wild-type littermates (n = 17) and Mpst-Tg B6 mice (n = 19). The unit is arbitrary. The X-axis shows pulse sound levels.
F H2S content in the frontal cortex of C3H wild-type littermates (n = 7) and Mpst-KO C3H mice (n = 7).
G H2S content in the frontal cortex of B6 wild-type littermates (n = 7) and Mpst-Tg B6 mice (n = 7).
H, I Levels of acid-labile sulfur (H) and bound sulfane sulfur (I) in the frontal cortex of C3H wild-type littermates (n = 7) and Mpst-KO C3H mice (n = 7).
J, K Levels of acid-labile sulfur (J) and bound sulfane sulfur (K) in the frontal cortex of B6 wild-type littermates (n = 7) and Mpst-Tg B6 mice (n = 7).
Data information: The values represent the mean  SEM. P values were calculated using Sidak’s multiple comparisons test (A–E) or unpaired two-tailed t-test (F–K).
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pathophysiology (Lewis et al, 2005), and PV-positive GABA
neurons are energy-demanding because of high-frequency firing
(Tremblay et al, 2016). The expression levels of Pvalb were lower
in the Mpst-Tg than in the non-Tg mice in RNA-seq analysis
(Fig 8E) and in qRT–PCR analysis (Fig 8F), suggesting that deficits
in the bioenergetic pathways could lead to functional impairments
in PV-positive interneurons.
Then we analyzed the concentrations of ATP (adenosine triphos-
phate) and ADP (adenosine diphosphate) and the ATP-to-ADP ratio
(Tantama & Yellen, 2014) as energy metabolism indices (Fig 9A–C).
In the frontal cortex of Mpst-Tg mice, the levels of ATP and ATP-to-
ADP ratio were lower than in the non-Tg mice (Fig 9A and C). To
confirm the energetic dysregulation of Mpst-Tg mice, we analyzed
their mitochondrial activity in vivo. We focused on cytochrome c
oxidase (complex IV), a component of mitochondrial respiratory
chain, because excessive H2S is known to inhibit cytochrome c
oxidase in a non-competitive manner (Goubern et al, 2007; Cooper
& Brown, 2008; Hancock & Whiteman, 2016). The enzymatic activity
of cytochrome c oxidase in mitochondria isolated from the Mpst-Tg
mice was significantly lower than the non-Tg littermates (Fig 9D).
To further examine the effect of dampened energy metabolism
on neural functions, we analyzed the density of dendritic spines
using primary culture of hippocampal neurons. Hippocampus is a
critical region involved in the neural circuit for the regulation of PPI
(Swerdlow et al, 2016). The spine density in dissociated hippocam-
pal neurons was found to be diminished in the Mpst-Tg mice (Fig 9E
and F) compared to that of non-Tg littermates, which is consistent
with the result of a human postmortem study (Rosoklija et al,
2000).
As an additional possibility, we assessed protein palmitoylation.
Specific palmitoyltransferases mediate the transfer of palmitoyl
groups to specific cysteine residues on a variety of proteins, modu-
lating the intracellular localization of the target proteins. Intrigu-
ingly, Pinner et al reported that the levels of protein S-
palmitoylation in most of the proteins tested were significantly




































































































Figure 5. Correlation between expression levels of genes encoding H2S-producing enzymes and between DNA methylation levels and gene expression levels.
A Correlation between relative expression levels of Mpst and Cth in B6 (n = 15) and C3H (n = 14) mice.
B Correlation between relative expression levels of MPST and CBS in postmortem brain samples (control, n = 93; schizophrenia n = 95). For demographic data, see
Appendix Table S7.
C Correlation between DNA methylation levels and relative expression levels of Mpst in B6 (n = 10) and C3H (n = 10) mice. Also see Appendix Fig S14.
D Correlation between DNA methylation levels and relative expression levels of CBS in postmortem brain samples from both control subjects and subjects with
schizophrenia (n = 181). Also see Appendix Fig S17, and Appendix Table S7 for demographic data.
Data information: Statistical evaluations were performed using Spearman’s rank correlation test.
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Figure 6. H2S-producing genes/proteins in human samples.
A–C Expression of MPST (A), CBS (B), and CTH (C) in postmortem brain samples from controls (n = 93) and schizophrenia patients (n = 95) (1st set). For demographic
data, see Appendix Table S7.
D Neurospheres from a control (left panel) and a schizophrenia patient (right panel). Scale bar, 50 lm.
E Relative expression of CBS in neurosphere samples from controls (n = 12 cell lines) and schizophrenia patients (n = 12 cell lines).
F Relative expression of MPST in peripheral blood cell (PBC) samples from controls (n = 56) and schizophrenia patients (n = 44). For demographic data, see
Appendix Table S9.
G Protein expression levels of MPST in plasma samples from controls (n = 56) and schizophrenia patients (n = 44). For demographic data, see Appendix Table S9.
H Expression patterns of MPST/MPST in scalp hair follicles. The upper panels show MPST protein expression, and the lower panels show MPST mRNA expression.
Nuclei were stained with DAPI (40 ,6-diamidino-2-phenylindole, dihydrochloride). Scale bars, 150 lm.
I Relative expression of MPST and CBS in scalp hair follicle samples from controls (n = 166) and schizophrenia patients (n = 149). For demographic data, see
Appendix Table S10.
Data information: The boxplot graphs summarize statistical measures (median, the 75th and 25th percentiles, and minimum and maximum data values) of the
distributions of relative target gene expression levels (using GAPDH as an internal control). BA8, Brodmann area 8 of postmortem brains. P values were calculated using
two-tailed Mann–Whitney U test.
ª 2019 The Authors EMBO Molecular Medicine 11: e10695 | 2019 9 of 24
Masayuki Ide et al EMBO Molecular Medicine
et al, 2016). We tested whether an elevated sulfide stress condition
might inhibit the protein S-palmitoylation reaction, because the
condition results in enhanced modification of cysteine residues (pro-
tein-Cys-SnH) (Kimura et al, 2015, 2017), thereby altering the reac-
tivity of cysteine residues. However, we did not detect any
alteration in the levels of protein S-palmitoylation analyzed by
means of the modified ABE (acyl-biotin exchange) method (For-
rester et al, 2011) in brains from Mpst-Tg or KO mice
(Appendix Figs S8–S11).
DNA methylation levels are correlated with the expression levels
of genes for H2S synthesis
There were no copy number variations for Mpst in the B6 and
C3H genomes that can explain the differential expression
(Appendix Table 15). By sequencing analysis of the 50-upstream
region of Mpst (~2,600 bp), we detected distinct guanine (G)
nucleotide stretches between the B6 (G10) and C3H genomes
(G12) (Appendix Fig S12), which, however, does not seem to
explain the differential gene expression. We tested the genetic
association of MPST and CBS with schizophrenia by analyzing
SNPs in more than 2,000 cases and a comparable number of
controls (Bangel et al, 2015; Balan et al, 2017), but detected no
association signals (Appendix Table 16). These results suggest
that the differential expression of Mpst/MPST and CBS in mouse
strains/disease brains is not due to inherent genetic variations.
Therefore, we examined the epigenetic mechanism underlying the
changes in expression.
We examined the DNA methylation status of the relevant genes.
There are two CpG islands at the Mpst locus in mice, one in the
promoter region (“CpG28”) and the other around exon 2 (“CpG64”)
(Appendix Fig S13). In “CpG64”, the CpG_31, CpG_42.43.44 (exam-
ined by probing the interval #1), and CpG_15 (examined by probing
the interval #7) sites were highly methylated in the C3H genome
compared to the B6 genome (Appendix Fig S14). The mean methyla-
tion levels of the three sites were positively correlated with the
expression levels of Mpst (Fig 5C).
For the human genes, the MPST locus has two CpG islands, as
observed in mice (Appendix Fig S15). There were multiple dif-
ferentially methylated cytosine nucleotides between schizophrenia
and control postmortem brain samples, but methylation levels at
those sites did not show any significant correlation with the
expression levels of MPST. In the CBS genomic region, there is
one CpG island in the intron 1 interval (Appendix Fig S16). In
the postmortem brain samples, the average methylation levels in
the 30 portion of “CpG227” (examined by probing the interval
#17) were higher in the schizophrenia samples than in the
controls (Appendix Fig S17) and exhibited a positive correlation
with the expression levels of CBS (Fig 5D). In neurosphere
samples, the 30 portion of “CpG227” (examined by probing the
interval #17) from schizophrenia with 22q11.2 deletion also
showed higher methylation levels than that from controls
(Appendix Fig S18).
These results suggest that least elevated expression levels of Mpst
in C3H brains and CBS in the schizophrenia postmortem brain
samples and iPSCs-derived neurospheres could be elicited by altered
DNA methylation levels in the CpG islands in the target gene
regions.
Inflammatory/oxidative stress in the early brain developmental
stage results in upregulated H2S/polysulfides production
H2S plays a protective role against oxidative and inflammatory
stresses (Kwak et al, 2003; Niu et al, 2015). Oxidative stress
depletes GSH and cysteine, which in turn enhances the activity of
H2S/polysulfides-producing enzymes to stimulate the synthesis of
H2S, cysteine, and GSH, leading to the protection of cells from
oxidative stress (Appendix Fig S19) (Kimura, 2010; Niu et al,
2015). H2S also attenuates the phosphorylation of mitogen-acti-
vated protein kinases as well as the activation of NF-jB and
caspase-3 and suppresses Bcl-2 expression under inflammatory
conditions (Tripatara et al, 2008). Based on the above, when
oxidative insults occur in an early neurodevelopmental stage, the
expression of both typical antioxidant and H2S/polysulfides
synthesis genes could be programmed to be maintained at higher
levels via epigenetic mechanisms. To examine this hypothesis, we
used a mouse model of maternal polyriboinosinic-polyribocytidilic
acid (poly-I:C) injection (maternal immune activation model)
(Meyer & Feldon, 2012; Giovanoli et al, 2013; Bundo et al, 2014),
which is known to perturb early neural development via inflamma-
tory/oxidative insults. Pregnant mice (B6) received five intraperi-
toneal injections of poly-I:C during embryonic days 12–16 (E12–
E16), and gene expression in the cortex was analyzed at 13–
14 weeks of age (Fig 10A). In this protocol, a “schizophrenia
endophenotype of increased L1 copy number” was observed
(Bundo et al, 2014). Interestingly, the expression levels of Mpst
and Cbs were elevated in the adult brain of this model, albeit Cth
expression was unchanged (Fig 10B–D).
As representative antioxidant genes, we examined the expression
of Sod1 and Sod2 (encoding superoxide dismutase), Cat (encoding
catalase), and Gpx1 and Gpx4 (encoding glutathione peroxidase)
(Smaga et al, 2015). The expression levels of all these genes were
significantly upregulated in the poly-I:C administered mice
compared to the controls (Fig 10E–I), although the fold changes
were small (for poly-I:C-to-control, Sod1 = 1.043, Sod2 = 1.024,
Cat = 1.051, Gpx1 = 1.050, Gpx4 = 1.079), suggesting small effect
sizes of individual expressional changes. The relative expression
levels of the two genes encoding H2S/polysulfides synthesis were
compared in the following pairwise comparisons: Mpst versus Cbs
(Fig EV4A), Mpst versus individual antioxidant genes (Fig EV4B–
D), and Cbs versus individual antioxidant genes (Fig EV4E–H).
Except for Mpst versus Gpx1, all the pairwise comparisons exhibited
positive correlation.
Conforming to the above “inflammatory/oxidative stress in the
early brain developmental stage” theory, inflammatory genes Il1b,
Il6, and Tnf were upregulated in C3H brain compared to B6 at some
point(s) during E (embryonic day) 16. 5 to P (postnatal day) 7 with-
out downregulation in any periods, though downregulation of Il6
was seen at an adult stage (12 weeks old) (Fig 10J–L). These devel-
opmental events could lead to an elevated H2S/polysulfides produc-
tion state in C3H mice compared to B6.
In human brains, CAT was upregulated in schizophrenia samples
compared to the controls (Fig EV5A), and the expression level of
this gene was positively correlated with that of MPST and CBS in
both the schizophrenia and control samples (Fig EV5B and C). The
IL1B/Il1b, IL6/Il6, or TNF/Tnf was not significantly upregulated in
the schizophrenia postmortem brain sample (Toyoshima et al,
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2016) and in the poly-I:C model mice (Appendix Fig S20). These
results support our hypothesis that upregulated H2S/polysulfides
production in adulthood can stem from oxidative/inflammatory
insults in the neurodevelopmental stage, occurring in a concerted
manner with the elevation of antioxidant gene expression and via
an epigenetic mechanism.
Discussion
Prior studies have repeatedly reported physiologically necessary/
beneficial and neuroprotective roles of H2S/polysulfides as gaso-
transmitters or neuromodulators (Szabo, 2007; Kimura, 2015;


























































Figure 7. Assessments of MPST in postmortem brains, and its association with symptom severity score and MPST in hair follicle samples as a biomarker.
A Protein expression levels of MPST in postmortem brain samples from controls (n = 22) and schizophrenia patients (n = 14) (2nd set). Also see Appendix Table S8 for
demographic data.
B Correlation between relative expression levels of MPST in postmortem brain samples from schizophrenia (n = 14) and symptom severity score rated by using the
Diagnostic Instrument for Brain Studies (DIBS). Also see Appendix Table S8 for demographic data.
C Receiver Operating Characteristic (ROC) curve of MPST/GAPDH levels in the hair follicle sample set, relative to schizophrenia occurrence. Schizophrenia patients
(n = 149) are the same to those used in Fig 6I. Regarding the discrimination efficiency of schizophrenia, the sensitivity and specificity were 73.6 and 47.2%,
respectively (area under the curve = 0.602).
Data information: The values represent the mean  SEM (A). P value was calculated using two-tailed Mann–Whitney U test (A). Correlation analysis was performed
using Spearman’s rank correlation test (B).
Source data are available online for this figure.
▸Figure 8. RNA-seq and RT–PCR analyses of Mpst-KO and Tg mice.A, B Volcano plot of RNA-seq analysis shows differentially expressed genes in the frontal cortex between Mpst-KO mice (A) and Mpst-Tg mice (B) in comparison to their
wild-type littermates; n = 6 in each group. Green and blue dashed lines indicate P value thresholds of 0.05 and 0.01, respectively. Top hits among the differentially
expressed genes (P < 0.05 and absolute fold change > 2) are highlighted as red in the plot.
C Gene ontology enrichment analysis (biological process) of dysregulated genes in Mpst-Tg mice visualized using a volcano plot for the enriched terms.
D Differentially expressed genes in Mpst-KO mice (upper panels) and Mpst-Tg mice (lower panels) (P < 0.05) in comparison to their WT or non-Tg littermates were
analyzed for the enriched canonical pathways.
E, F Gene expression of Pvalb in non-Tg and Mpst-Tg mice examined by RNA-seq (n = 6 in each group) (E) and by qRT–PCR analysis (n = 10 in each group, but an
outlier was excluded in WT) (F).
Data information: The values represent the mean  SEM. P values were calculated using unpaired two-tailed t-test (E, F).
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(Paul et al, 2014). In contrast, in this study, we started by analyzing
the molecular underpinnings of the sensorimotor gating function
against acoustic stimuli in mice and, as a consequence, provide the
first evidence that excess H2S/polysulfides production could under-
lie the pathophysiology of, at least, a subset of schizophrenia.
Although we revealed the elevated sulfide stress in schizophrenia
pathophysiology, in the light of Mpst from our proteomics study,
upregulation of a combination of the three genes encoding H2S/
polysulfides-synthesizing enzymes, namely, Mpst (MPST), Cbs
(CBS), and Cth (CTH), was observed in mouse models and human
schizophrenia samples. Regarding such combination, we speculate
that depending on the tissue-specific variability in the expression
levels of these genes, a gene network including predominantly
expressed one in the relevant tissue (see Fig EV3) may leverage
maximum control of H2S/polysulfides production. Hydrogen sulfide
is a highly bioactive agent in organisms, thus even small changes in
its production levels should have serious consequences in life.
Therefore, we believe that even small changes detected in this study
can be biologically meaningful. We further demonstrated that
altered expression of these genes could be, at least in part, primed
by changes in genomic DNA methylation markers, although their
direct link remains to be proved. We demonstrated that such epige-
netic changes can be traced back to inflammatory/oxidative insults
in the early brain developmental stage by analyzing the poly-I:C
model, which is consistent with, and a novel aspect of, the
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Figure 9. Energy metabolism and spine analyses of Mpst-Tg mice.
A–C Concentrations of ATP and ADP, and ATP-to-ADP ratios in non-Tg (n = 5) and Mpst-Tg (n = 8) mice (both age of 6 weeks).
D Cytochrome c oxidase activity in non-Tg (n = 6) and Tg (n = 6) mice (both age of 6 weeks).
E, F Fluorescence images of dendritic spines of dissociated hippocampal neurons (E16.5) of non-Tg and Mpst-Tg mice (E) and their quantification (F). N = 50–70 images
from 10 to 15 cells. Scale bar, 10 lm.
Data information: The values represent the mean  SEM. P values were calculated using unpaired two-tailed t-test.
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Figure 10. Gene expression in the maternal immune activation mouse model and in multiple developmental stages.
A Schematic illustration of the experimental design of maternal immune activation mouse. B6 mice were used, and gene expression was examined in the frontal
cortex.
B–I Target gene expression levels were relative to that of Actb. PBS-injected mice, n = 25; poly-I:C-injected mice, n = 13.
J–L Comparison of expression levels of typical inflammatory genes Il1b (J), Il6 (K), and Tnf (L) in four developmental points of brains between B6 and C3H mice. “12W”
samples were analyzed separately from the others. Whole cortex for E16.5 (n = 15–20), P0 (n = 17), and P7 (n = 17–18), and frontal cortex for 12W (n = 5) were
used for analysis. E16.5, embryonic day 16.5; P0, at birth; P7, postnatal day 7; 12W, 12 weeks of age.
Data information: The values represent the mean  SEM. P values were calculated using unpaired two-tailed t-test.
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reason that upregulation of the H2S/polysulfides synthesis genes
and representative antioxidant genes can be orchestrated against an
oxidative event in a complementary manner because H2S/polysul-
fides can mitigate oxidative stress (Kimura, 2010; Niu et al, 2015;
Wallace & Wang, 2015). Notably, endogenous H2S also enhances
the activities of catalase and superoxide dismutase in bacteria
(Shatalin et al, 2011).
To determine the functional consequence of excess H2S/polysul-
fides production under disease conditions, we performed RNA-seq
analysis using Mpst-KO and Tg mice and detected the DARPP32 and
energy metabolism (glycolysis and TCA cycle) systems among the
top canonical pathways, dysregulation of which has been docu-
mented in schizophrenia (Kunii et al, 2014; Wang et al, 2017;
Zuccoli et al, 2017). In particular, several lines of investigation have
suggested a reduced capacity of the TCA cycle in schizophrenia
(Bubber et al, 2011; Paredes et al, 2014). Concordant with those
reports, our Mpst-Tg mice showed reduced ATP concentration and
decreased ATP-to-ADP ratio, and deficits in cytochrome c oxidase
(complex IV) activity, compared to the non-Tg animals. These
dampened bioenergetic processes may have led to decreased Pvalb
expression, a functional marker of PV-positive interneurons, and
diminished spine density. The brain is deemed to be susceptible to
H2S, because in the brain, the activity of SQOR (sulfide quinone
oxidoreductase), a H2S-metabolising enzyme, was lower than in
peripheral tissues (Linden et al, 2012). The detailed mechanistic
links between these issues, including in vivo stoichiometry of H2S/
H2Sn on the suppression of complex IV activity (Szabo et al, 2014;
Modis et al, 2016), should be clarified in future.
There are several cases in which excess H2S production results
in cognitive impairments. The CBS gene is encoded on chromosome
21 (21q22.3), which is associated with trisomy in Down syndrome
(DS). Overexpression of CBS may cause developmental abnormali-
ties in cognition in children with DS (Ichinohe et al, 2005). Barbaux
et al (2000) reported that the CBS 844ins68 allele was significantly
underrepresented in children with high IQs. The CBS 844ins68
allele carries a 68-bp insertion consisting of a duplicated intron 7/
exon 8 boundary (Sebastio et al, 1995) and exhibits enhanced activ-
ity compared to the WT allele (Barbaux et al, 2000). Recent
evidence has showed that increased copy number of Cbs elicits
memory-related cognitive deficits in DS mouse models, by
perturbing synaptic activity, possibly through H2S signaling (Mare-
chal et al, 2019). These results suggest that excess H2S induced by
enhanced CBS/Cbs activity may contribute to at least some aspect
(s) of cognitive impairments manifested in schizophrenia (Raja-
gopal et al, 2014). Similarly, ethylmalonic encephalopathy (EE;
OMIM #602473), an autosomal recessive mitochondrial disease
associated with progressive neurological failure, is caused by muta-
tions in ETHE1 (Burlina et al, 1991; Mineri et al, 2008). ETHE1
encodes a ubiquitous mitochondrial sulfur dioxygenase (SDO)
(Tiranti et al, 2009) that eliminates H2S (Hildebrandt & Grieshaber,
2008).
Because H2S is distributed systemically, some somatic diseases
are also affected by H2S. Ulcerative colitis is an inflammatory bowel
disease, and H2S overproduction contributes to the etiology of this
disease (Roediger et al, 1997). On the other hand, H2S is present in
joints and acts as a proinflammatory mediator (Muniraj et al, 2017);
therefore, rheumatic diseases might be associated with decreased
production of H2S. Comorbidity has been reported between
ulcerative colitis and schizophrenia (Cucino & Sonnenberg, 2001),
whereas rheumatoid arthritis occurs at a relatively low frequency in
schizophrenia patients (Leucht et al, 2007).
In schizophrenia, biomarkers are of cardinal importance for early
intervention and improved prognoses (Morrison et al, 2012; Fusar-
Poli et al, 2013). Biomarkers can be also used to categorize patients
and determine optimal therapeutics. Our postmortem study
suggested a positive correlation between symptomatic severity and
“sulfide stress”, and in living patients the present results highlight
the potential benefit of examining MPST expression levels in scalp
hair follicles. The use of scalp hair follicles is advantageous because
of the convenience and noninvasiveness of sampling (Maekawa
et al, 2015).
Meanwhile, enhanced inflammatory conditions in schizophrenia
are repeatedly reported, in particular around onset and in active
phase, which may be state-dependent (temporal) (Smaga et al,
2015; Koga et al, 2016; Watkins & Andrews, 2016). Excess H2S/
polysulfides production may be a more basic and persistent
phenomenon like, “continuous bass”, in the realm of “reductive
response” which has not been explicitly addressed in the previous
studies. The precise contribution of these two biological reactions to
disease process remains elusive.
In summary, although H2S/polysulfides are necessary for mainte-
nance of normal cellular functions, an excessive amount of H2S/
polysulfides may impair brain functions; we propose to name this
phenomenon “sulfide stress”, which could be a novel form of
“reductive stress” (Perez-Torres et al, 2017). One of the potential
origins of “sulfide stress” could be oxidative/inflammatory insults
in neurodevelopment and is epigenetic priming as a mechanism,
and its consequence could include damped energy metabolism.
Elucidation of the precise role of “sulfide stress” in schizophrenia
and other mental disorders will facilitate the establishment of a
novel paradigm for drug development.
Materials and Methods
Experimental animals
For the proteomics study, B6 (C57BL6/NCrj) and C3H (C3H/
HeNCrj) mice were purchased from Japan SLC (Shizuoka, Japan).
For the other studies, B6 (C57BL/6NCrl) and C3H (C3H/HeNCrl)
mouse strains were obtained from Japan’s Charles River Laborato-
ries (Kanagawa, Japan). The change in substrains was due to the
introduction of the International Genetic Standardization Program
(https://www.crj.co.jp/cms/cmsrs/pdf/company/rm_rm_r_igs.pdf)
after the proteomics study. The animals were bred in our facilities
for 2 weeks before the experiments, housed by strain in groups of
four, using standard cages in a temperature- and humidity-
controlled room with a 12-h light/dark cycle (lights on at 0800). The
animals had free access to standard laboratory chow and tap water.
The experimental procedures conformed to NIH guidelines for
animal welfare and were approved by the Animal Ethics Commit-
tees of all the relevant institutes. The mouse studies contained no
randomization procedures for group allocation and were conducted
in an open-label format. Only male animals were used for all the
experiments except for the data for Fig 10J–L, samples for E16.5,
P0, and P7.
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Sample preparation for proteomics analysis
Eight-week-old mice were decapitated, and the bilateral prefrontal
cortex (AP > +2 mm from the bregma) of each brain was dissected
and frozen immediately. The spleen was also dissected, rinsed in
ice-cold phosphate-buffered saline, homogenized on a stainless steel
fine mesh net, and filtered using Eagle’s MEM supplemented with
10% FBS. The filtered cells were centrifuged, and the supernatants
were removed. Red blood cells were ruptured in an NH4Cl solution
and washed with Eagle’s MEM, and then, residual lymphocytes
were collected. All lymphocyte and brain samples were stored at
80°C until protein preparation. Tissues were homogenized and
sonicated in ice-cold lysis buffer (20 mM Tris, 7 M urea, 2 M
thiourea, 4% (w/v) CHAPS, 10 mM DTT, 1 mM EDTA) containing
protease and a phosphatase inhibitor cocktail (P8340, P2850, P5726;
Sigma, St Louis, MO, USA). After centrifugation of the lysate
(1.7 × 104 g), the supernatant was recovered and assayed for
protein concentration using the Bradford method.
2D-DIGE analysis of brain and splenic lymphocyte samples from
mice: labeling
The experimental design for the 2D-DIGE analysis in this study is
shown in Appendix Table S1. Mixtures from each sample (100 mg of
protein) derived from brain or lymphocytic tissue were pooled as an
internal standard. A 100-lg aliquot of protein from each sample was
labeled with Cy3 for B6 mice, Cy5 for C3H mice, and Cy2 for the
internal standard and left on ice for 30 min in the dark. The labeling
reaction was quenched with 2 ll of 10 mM lysine. Each pair of
labeled B6- and C3H-derived samples was then combined with the
labeled internal standard and added to an equal volume of 2× sample
buffer [9 M urea, 4% (w/v) CHAPS, 2.4% (v/v) DeStreak reagent
(GE Healthcare, Chicago, IL, USA), 1% (v/v) IPG buffer
3–10 (GE Healthcare)] and diluted with rehydration buffer [9 M urea,
2% CHAPS, 1.2% (v/v) DeStreak reagent, 0.5% (v/v) IPG buffer 3–
10], to a final volume of 250 ll, prior to loading onto the 2D gel.
2D gel electrophoresis
One Immobiline DryStrip [pH 3–10, 13 cm (GE Healthcare)] was
passively rehydrated with each combined sample for more than
10 h at room temperature. For the first dimension of electrophore-
sis, the rehydrated strips were focused using Ettan IPGphor II (GE
Healthcare) for a total of 82,000 Vh. The strips were then reduced
and alkylated according to the manufacturer’s protocol. For the
second dimension of gel electrophoresis, the strips were loaded onto
12% polyacrylamide gels in a Hoefer SE 600 Chroma system, and
proteins were resolved at 15 mA/gel for 7 min and then at 30 mA/
gel for the duration of the run.
Data analysis for 2D gel electrophoresis
Separated gels were scanned using a Typhoon 9400 digital scanner
(GE Healthcare), and images were analyzed by differential analysis
software (DeCyder, version 5.0, GE Healthcare). Spots were recog-
nized using a Differential In-gel Analysis (DIA) module, with the
estimated number of spots for each co-detection procedure set to
5,000 and filtered using default settings. Intergel matching and
statistical analyses were performed using the Biological Variable
Analysis (BVA) module.
Protein identification: SYPRO ruby and silver staining
Three-hundred-microgram aliquots of protein from each tissue
sample were diluted in rehydration buffer to a final volume of
250 ll and separated by 2D gel electrophoresis as described above.
The gels were then stained with SYPRO Ruby Protein Gel Stain
(Molecular Probes) according to the manufacturer’s protocol. The
resulting fluorescent images were scanned. Protein spots were
excised and destained with 25 mM (NH4)HCO3/50% (v/v) acetoni-
trile (ACN), followed by an additional wash in 100% ACN using
Xcise (Shimadzu), and then dried to enable in-gel digestion.
For large-scale analysis, 500 lg of protein was focused using a
24-cm Immobiline DryStrip pH 3–7 (GE Healthcare) for a total of
160,000 Vh. In the second dimension, the run was performed
using an Ettan DALT Six (GE Healthcare). Gel spots were stained
with a Plus One Silver Stain Kit according to the manufacturer’s
instructions and excised with an Ettan Spot Picker (GE Health-
care). Gels were then destained in buffer [15 mM potassium hexa-
cyanoferrate (III), 50 mM sodium thiosulfate], washed in 100%
ACN, and dried.
In-gel digestion and MALDI-TOF mass spectrometry (MS)
In-gel digestion was performed using 3 lg/ml trypsin in 50 mM
(NH4)HCO3 with 0.1% (w/v) N-octylglucoside at 37°C for 16 h.
Digested peptides were extracted with 5% (v/v) formic acid/50%
ACN, dried, diluted in 0.1% (v/v) trifluoroacetic acid (TFA), and
then desalted and concentrated in a PerfectPure C-18 tip (Eppen-
dorf). Peptides were eluted onto a MALDI target plate with matrix
solution (5 mg/ml a-cyano-4-hydroxycinnamic acid (CHCA), 0.1%
TFA, 50% ACN, 500 pmol of bradykinin, 400 pmol of ACTH) and
dried at room temperature. The peptide masses were then deter-
mined by MALDI-TOF MS. Mass spectra were obtained using an
AXIMA CFR plus (Shimadzu, Kyoto, Japan) in positive ion reflec-
tron mode, and the mass axis was calibrated using bradykinin and
ACTH. Raw data were processed using Kompact (ver. 2.4,
Shimadzu), and the peak list was generated with default parameters
as follows: minimum mass: 600, maximum mass: 3,500, minimum
isotopes: 2, maximum intensity variation: 50, overlapping distribu-
tions: on, and minimum peak percent: 30. The identified proteins
were verified by manual comparisons of the computer-generated
fragment ion series of the predicted peptide with experimental MS
data. The mass spectrum for each spot was analyzed by PMF using
MASCOTTM software (ver. 2.2.1, Matrix Science) (http://
www.matrixscience.com) and used for PMF analysis against the
UniProt or NCBI nonredundant protein databases. Database search-
ing was performed using the following settings: (i) Mus musculus,
(ii) trypsin digestion with up to 1 missed cleavage, (iii)  0.5 Da
error, (iv) cysteine carbamidomethylation as a fixed modification,
and methionine oxidation as a variable modification. After exclud-
ing unmatched peptides to avoid contaminations of overlapping
spots, identities were assigned when score values were returned
with P value < 0.05 for a false positive and were confirmed by
manual inspection of the spectra. Each protein was confirmed with
2D Western blot analyses described below.
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1D and 2D Western blot analyses: antibodies
We generated rabbit polyclonal antibodies against the N-terminal
(DASWYLPKLGRDARREF) and C-terminal (YMRAQPEHIISEGRGKT)
regions of mouse Mpst [designated as anti-Mpst #1 and anti-Mpst
#2, respectively]. For 1D Western blot analyses, the anti-Mpst #1
and #2 and anti-a-tubulin (T5168, Sigma) antibodies were diluted in
1:100, 1:1,000, and 1:20,000, respectively. The anti-Mpst #1 (dilu-
tion 1:500) and commercially sourced antibodies, which included
anti-GRP 75 (Sigma; dilution 1:2,000) for Hspa9 and anti-NPM1
(ProteinTech Group, Rosemont, IL, USA; dilution 1:1,000) for
Npm1, were used in 2D Western blot analyses of both frontal cortex
and lymphocytes. Anti-peroxiredoxin-6 (Abcam, Cambridge,
England) for Prdx6 was diluted in 1:1,000 (frontal cortex) and 1:500
(lymphocytes), and anti-NME2 (Abgent, San Diego, CA, USA) for
Nme2 was diluted in 1:100 (frontal cortex) and 1:50 (lymphocyte)
(expression levels of Prdx6 and Nme2 in lymphocytes were low).
Western blotting
For 2D Western blotting, 300 lg of protein was separated by 2D gel
electrophoresis using a 13-cm Immobiline DryStrip pH 3–10 or pH
4–7 (GE Healthcare) using the same procedure as described above,
except for the rehydration buffer [9 M urea, 2% CHAPS, 0.28%
(w/v) DTT, 0.5% (v/v) IPG buffer 4–7] in the pH 4–7 strip. Proteins
were transferred to PVDF membranes by semidry blotting, and the
membranes were stained with Deep Purple (GE Healthcare) accord-
ing to the manufacturer’s protocol. Fluorescent signals were
scanned with Typhoon 9400, after which the membranes were
soaked in transfer buffer prior to antibody binding. Membranes
were incubated in blocking solution containing 5% skimmed milk
in TBS with 0.05% Tween 20 (TBS-T) for 1 h and then incubated
overnight at 4°C with primary antibodies in blocking solution. The
membranes were then washed in TBS-T and probed with horse-
radish peroxidase (HRP)-conjugated anti-rabbit or anti-mouse IgG
antibodies (Sigma). Signals were detected using Western Blotting
Luminol Reagent (Santa Cruz Biotechnology, Dallas, Texas, USA).
The fluorescent signals on the 2D Western blots were detected using
a Typhoon 9400. Chemiluminescent signals were visualized using a
Typhoon 9400 or LAS-3000 (Fuji Film, Tokyo, Japan). Fluorescent
and chemiluminescent images were merged using FluorSep software
(version 2.2, GE Healthcare). For standard 1D Western blotting, 20-
lg protein samples were loaded onto 12% SDS–polyacrylamide gels
and separated by electrophoresis. Proteins were transferred to PVDF
membranes by semidry blotting, and the membranes were incu-
bated overnight at 4°C with primary antibodies in blocking solution.
The membranes were then washed in TBS-T and probed with horse-
radish peroxidase (HRP)-conjugated anti-rabbit (Sigma, cat no. 12-
348) or anti-mouse IgG antibodies (Sigma, cat no. 12-349).
DNA sequencing and database searching
Genomic DNA samples were extracted using a standard phenol/chlo-
roform method from mouse tails and amplified using fluorescently
labeled forward and reverse primers and ExTaq polymerase (TaKaRa
Bio, Shiga, Japan). Sequencing was performed using the BigDye
Terminator Cycle Sequencing FS Ready Reaction Kit ver. 3.1 (Applied
Biosystems, Foster City, CA, USA) and an ABI PRISM 3730 genetic
analyzer (Applied Biosystems). Genomic sequences and SNPs were
examined using the UCSC Genome Bioinformatics online database
(http://genome.ucsc.edu/cgi-bin/hgGateway: version Dec. 2011).
Measurement of H2S, acid-labile and bound sulfur
After 10- to 12-week-old mice were decapitated, brains were quickly
removed and sagittally divided into two groups. Using one hemi-
sphere, H2S levels were measured according to a previously reported
method (Kimura et al, 2015). Using the other hemisphere, acid-labile
and bound sulfur levels were measured according to methods
described elsewhere (Ishigami et al, 2009; Shibuya et al, 2009).
Generation of Mpst knockout (KO) mice
We generated Mpst-deficient mice by genome editing using the
CRISPR/Cas9 nickase in the genetic background of the C3H strain
(Appendix Fig S6). First, the sgRNAs [Mpst-upstream (target
sequence: 50-GGAGAGACAAGCCTGCATTCAGG-30) at intron 1 and
Mpst-downstream (target sequence: 50-GTGGGTGGCGGAGGCTCT
GAAGG-30) at exon 2, where the underlined bases indicate the PAM
sequences] were synthesized in vitro (T7 gRNA Smart Nuclease
Synthesis Kit, System Biosciences, Mountain View, CA, USA)
following the manufacturer’s instructions. C3H zygotes were
microinjected with the cocktail [5 ng/ml Cas9 nickase mRNA (Sys-
tem Biosciences) and 5 ng/ml each of the two sgRNAs]. The
injected zygotes were transplanted into the uteri of pseudopregnant
dams, and the targeted region of the Mpst gene from the resultant
pups, which were obtained by cesarean section, was examined by
direct sequencing of PCR products amplified from the template
DNAs extracted from the tail with primer set A (forward: 50-
CTGTTTTGCAGCCCCGCAATCT-30, reverse: 50-TAGGTACCAGGACG
CGTCCAGTAA-30). Mutated alleles of the promising founders were
further analyzed by sequencing of the PCR products that were
subcloned into pCR2.0 (Invitrogen, Grand Island, NY, USA). When
the selected founder (#461) carrying a 4-bp deletion downstream of
the start codon in exon 2 of Mpst reached sexual maturity, in vitro
fertilization was performed with C3H strain-derived oocytes to
obtain heterozygous mice harboring the mutated allele. The
heterozygous males and females, at sexual maturity, were inter-
crossed to produce homozygotes and control littermates. Routine
genotyping of the mice was conducted on an ABI 3130xI genetic
analyzer (Life Technologies, Carlsbad, CA, USA) followed by
genomic PCR using primer set A, which produced 152- and 156-bp
fragments from the deleted allele and unedited allele, respectively.
To confirm loss of the Mpst protein in homozygotes, the brain
tissues of the animals were subjected to Western blot analysis with
an anti-Mpst antibody (Nagahara et al, 1998).
Generation of Mpst-transgenic (Tg) mice
Mpst-Tg mice were generated as described elsewhere (Ohnishi et al,
2010) with minor modifications, using the pCAGGS backbone
harboring the CAG promoter (Niwa et al, 1991) (Appendix Fig S7)
in the genetic background of B6. The HA-tagged Mpst ORF derived
from B6 was cloned into the XhoI site of pCAGGS, and the resultant
plasmid was microinjected into B6 zygotes after linearization with
Sca I. The injected zygotes were transplanted into the uteri of
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pseudopregnant ICR dams. As a primary screening, genomic DNAs
from the tail of the pups were subjected to genomic PCR to identify
animals with the transgene using the three primer pairs covering dif-
ferent parts of the construct (pair A: pCAGGS_FW2: 50-TAACCATGT
TCATGCCTTCT-30 and Mpst_Rv1: 50-TTTACTGAGCCAGGGATGT-30,
pair B: Mpst_Fw1: 50-ATCTACGACGACAGTGACCA-30and b-globi-
nA_Rv1: 50-GTCGAGGGATCTCCATAAGA-30, and pair C: CAG_Fw4:
50-ACCTGGGTCGACATTGATTA-30 and CAG_Rv2: 50-AACATGGT
TAGCAGAGGCTC-30). As a secondary screening, proteins extracted
from the tail were subjected to SDS–PAGE and Western blotting
with anti-Mpst and anti-HA antibodies to identify HA-Mpst-positive
animals. Here, notably, the CAG promoter is known to be ubiqui-
tously active among various tissues, including the tail and brain,
enabling us to expect high-level expression in the brains of animals
that exhibited transgene expression in the tail. Since founder #737
showed the highest expression of the transgene among the candi-
dates, the offspring animals of this founder were generated. Trans-
gene expression was examined by Western blot analysis.
To identify the integration site of the transgene, next-generation
sequencing of genomic DNA obtained from the tail was performed
by TaKaRa Bio. The raw sequence data were analyzed using multi-
ple tools, including BWA (http://biobwa.sourceforge.net/), Picard
(http://picard.sourceforge.net/), BEDTools (http://code.google.
com/p/bedtools/), BreakDancer (http://breakdancer.sourceforge.
net/), and PinDel (http://trac.nbic.nl/pindel/). Routine genotyping
of mice after identification of the integration site was conducted by
multiplex PCR using a primer set (Chr_BP1-F: 50-GATGGGCCA
CACTCTTAGAGCCTCTG-30, Insert_BP1-R: 50-AGCGCAGAAGTGGTC
CTGCAACTT-30 and Del_BP1-R: 50-GGAGTTTGTTTGGGTCTTTTGT
TGCTTG-30) that produced 503- and 411-bp fragments from the Tg-
integrated and normal alleles, respectively.
Behavioral analysis
PPI scores and ASR against acoustic stimuli in mice were measured
according to previously published methods (Shimamoto et al,
2014). Sodium hydrosulfide (NaHS) was purchased from Nacalai
Tesque (Kyoto, Japan). This compound was dissolved in saline and
administered to a mouse intraperitoneally at a dose of 1 mg/kg or
10 mg/kg body weight once a day. Control mice were administered
saline.
Real-time quantitative RT–PCR and digital RT–PCR
Single-stranded cDNA for each total RNA sample was synthesized
using SuperScript III RT (Invitrogen), oligo(dT), and random
hexamers (Maekawa et al, 2015). Real-time quantitative PCR analysis
was conducted using an ABI7900HT Fast real-time PCR system
(Applied Biosystems). The TaqMan probes used were TaqManTM Gene
Expression Assay products (Applied Biosystems). All real-time quanti-
tative PCR data were captured using SDS v2.4 (Applied Biosystems).
The ratio of the relative concentration of the target molecule to that of
the GAPDH gene (target molecule/GAPDH gene) was calculated. All
reactions were performed in triplicate based on a standard curve
method. Outliers (more or less than mean  2SD) were excluded.
Absolute quantitative analysis of mRNAs was conducted using
the QuantStudioTM 3D digital PCR system (ThermoFisher, Waltham,
MA, USA). The TaqMan probes used were TaqManTM Gene
Expression Assay products (Applied Biosystems). All absolute quan-
titative data were captured using QuantStudioTM 3D AnalysisSuiteTM
software (ThermoFisher).
Human samples
A set of RNA samples derived from BA8 was obtained from the
Victorian Brain Bank Network (http://www.mhri.edu.au/brain-ba
nk) (1st set). Demographic data of the BA8 samples are described in
Appendix Table S7. Another set of postmortem brain tissues (BA17)
from schizophrenia and age-matched controls were obtained from
the Postmortem Brain Bank of Fukushima for Psychiatric Research
and Brain Research Institute, Niigata University, Japan (in total
n = 22 for schizophrenia and n = 14 for control) (2nd set) (Ohnishi
et al, 2019) (Appendix Table S8).
Characteristics of the human iPS cells and neurosphere samples
analyzed are described elsewhere (Bundo et al, 2014; Maekawa
et al, 2015; Toyoshima et al, 2016). Peripheral whole-blood samples
were collected, and total RNA was extracted using the RiboPureTM-
Blood Kit (Ambion, Grand Island, NY, USA). MPST levels in plasma
were measured using a human ELISA kit for 3-mercaptopyryvate
sulfurtransferase (MST) (Wuhan USCN Business, Hubei, China).
Subjects consisted of 44 subjects with schizophrenia and 56 control
subjects, all from the Tokyo area of Japan. Diagnoses were made in
accordance with the DSM-IV criteria. Demographic data are shown
in Appendix Table S8.
Preparation of scalp hair follicle samples and the method used
for RNA extraction from those samples are described elsewhere
(Maekawa et al, 2015). We collected 10–12 hair follicles from
an individual, with RNA yield per one hair follicle being
58.09  27.61 ng (mean  SD). We did not amplify RNA but pre-
amplified cDNA of all the target genes before quantification, using
TaqMan PreAmp Master Mix (ThermoFisher). Demographic data
are shown in Appendix Table S9.
The human studies, including the use of iPS cells, conformed to
the principles set out in the WMA Declaration of Helsinki and the
NIH Belmont Report and were approved by the Ethics Committees
of all relevant institutes, and all the participants provided written
informed consent to participate in the study.
Immunohistochemistry and in situ hybridization of MPST/MPST in
hair follicles
Analysis of MPST protein expression in scalp hair follicle samples
was performed as previously reported (Maekawa et al, 2015, 2019).
Primary polyclonal rabbit antibody was used for MPST detection
(Santa Cruz Biotechnology (Dallas, TX, USA); dilution 1:100). The
secondary antibodies used were Alexa Fluor 488- or 594-labeled
goat anti-rabbit IgG or goat anti-guinea pig IgG (Life Technologies;
dilution, 1:400).
Sequences for in situ probes were amplified by PCR using the
appropriate primers and cloned into pGEM-T (Promega, Fitchburg,
WI, USA). Digoxigenin (DIG)-labeled RNA probes were prepared
with a template plasmid and the DIG RNA Labeling Kit (Roche,
Basel, Switzerland). After drying, the sections were fixed for 10 min
in 4% paraformaldehyde in PBS at room temperature. The sections
were rinsed with PBS and incubated with 0.5 lg/ml proteinase K (in
10 mM Tris–HCl, pH 7.4, 1 mM EDTA) for 5 min at 37°C. Fixing was
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repeated with 4% paraformaldehyde in PBS for 10 min, followed by
rinsing with PBS. Probes were diluted (1:200) with hybridization
buffer [5× SSC, 50% formamide, 1% (v/v) SDS, 50 lg/ml heparin,
50 lg/ml tRNA], and 300 ll of each sample was applied to a slide.
After 16 h of incubation at 65°C, the sections were washed, first with
MABT buffer [100 mM maleic acid, pH 7.5, 150 mM NaCl and 0.3%
(v/v) Tween 20] twice for 5 min, then with washing buffer [1× SSC,
50% formamide, 0.1% (v/v) Tween 20] twice for 30 min at 65°C,
and finally with MABT buffer twice for 5 min. Then, the slides were
incubated in PBS containing 3% H2O2 for 30 min and washed and
blocked with blocking reagent (Roche) for 1 h. After blocking, the
slides were incubated with HRP-conjugated anti-DIG antibody
(1:500; Roche) in blocking reagent for 16 h at 4°C. The samples were
washed three times (5 min each) with MABT buffer. Signals were
visualized by incubating the sample with Tyramide-Alexa Fluor 488
(1:200) for 10 min using a TSA kit (Life Technologies). After three
rinses with PBS, coverslips were placed on the slides for examina-
tion. Fluorescence signals were detected using an FV1000 confocal
laser-scanning microscope (Olympus, Tokyo, Japan).
Western blot analysis of MPST in postmortem brain samples
Western blot analysis was performed as per our previous report
(Ohnishi et al, 2019). The protein (40 lg/lane) was analyzed in
Western blot with anti-MPST (Nagahara et al, 2013; dilution
1:3,000) and anti-GAPDH (Santa Cruz Biotechnology, sc-20357;
dilution 1:5,000) antibodies. The chemiluminescent intensities for
the signal of MPST were normalized to those of GAPDH.
Receiver operating characteristic (ROC) curve analysis
The equations for calculation of sensitivity and specificity were
“sensitivity = number of true positives/(number of true posi-
tives + number of false negatives)” and “specificity = number of true
negatives/(number of false positives + number of true negatives)”
with the criterion that relative expression levels of MPST mRNA
above a cut-off value were deemed as positive for schizophrenia.
We used the Mann–Whitney U test (two-tailed) to detect signifi-
cant changes in the expression levels of each gene. Correlations of
confounding factors for MPST gene expression were calculated by
Spearman’s rank correlation test.
RNA-seq analysis
Transcriptome analysis in the frontal cortical brain region was
performed by RNA-seq in (a) Mpst-KO mice (n = 6) versus WT
controls (n = 6) and (b) Mpst-Tg (n = 6) versus littermate (non-Tg)
controls (n = 6). Total RNA from the frontal cortical brain region
was extracted (miRNeasy Mini Kit, Qiagen, Hilden, Germany), and
the quantity and quality of RNA were estimated (2200 TapeStation
system, Agilent, Santa Clara, CA, USA). Samples with RNA integrity
number (RIN) ≥ 8.7 were further used for library preparation with
200 ng of total RNA according to the manufacturer’s instructions for
the TruSeq Stranded mRNA Sample Prep Kit (Illumina, San Diego,
CA, USA). Briefly, poly-A-containing mRNA was purified using poly-
T oligo-attached magnetic beads and then heat fragmented and
reverse transcribed into first-strand cDNA using reverse transcriptase
and random primers. Second-strand cDNA synthesis was performed
by incorporating dUTP followed by addition of a single “A” nucleo-
tide at the 30 ends of the blunt fragments to prevent ligation of
double-stranded cDNA. After adapter ligation (including multiplex-
ing barcodes), the cDNA fragments were enriched by PCR (15 cycles)
to create the final cDNA library. The quality, size distribution, and
quantity of the cDNA libraries were assessed (2100 Bioanalyzer,
Agilent), and the libraries were further sequenced in 100-bp paired-
end read format on the HiSeq 2500 platform (Illumina).
The RNA-seq data for the individual samples were demultiplexed
using the unique index adapters. The quality of the sequence reads
was evaluated by FastQC (http://wwwbioinformaticsbabrahamacuk/
projects/fastqc), and the reads were trimmed for adapter sequences
and low-quality bases using the FASTX tool kit (http://hannonlabcsh
ledu/fastx_toolkit/indexhtml). The reads were further mapped to the
mouse reference genome (GRCm38/mm10, http://hgdownload.soe.
ucsc.edu/goldenpath/mm10/chromosomes/) using TopHat with
default parameters (v.2.0.14) (Trapnell et al, 2012), utilizing the
aligner Bowtie2 (v.2.2.5) (Langmead et al, 2009). The expression
levels were quantified using Cufflinks (v.2.2.1) (Trapnell et al, 2012)
based on the read mapping and calculated as fragments per kilobase
of transcript per million mapped reads (FPKM), corresponding to the
UCSC gene annotations for mm10 (http://hgdownload.soe.ucsc.ed
u/goldenpath/mm10/database/refFlat.txt.gz). To test the statistical
significance for differential expression among the comparison groups,
Student’s t-test on log-transformed FPKM values (log2 FPKM) was
applied. P values < 0.05 were considered statistically significant, and
these reads were further analyzed for gene ontology enrichment and
pathway analysis. Visualization of differentially expressed genes
using volcano plots was performed in R (https://www.r-project.org).
Differentially expressed genes were tested for gene ontology enrich-
ment and pathway analysis. Gene ontology enrichment analysis was
performed in the PANTHER Overrepresentation Test (http://panthe
rdb.org/webservices/go/overrep.jsp, annotation version and release
date: GO Ontology database, released on 2018-06-01). Reported P
values were corrected for multiple testing using the FDR method.
Pathway enrichment was performed using Ingenuity Pathway Analy-
sis (IPA) (Qiagen, content version: 36601845, release date: 2017-06-
22). The statistical significance of the enriched canonical signaling
pathways was calculated using Fischer’s exact test. P values < 0.05
were considered statistically significant.
Analysis of metabolites
To minimize postmortem degradation, we subjected mice to
high-energy focused beam microwave irradiation (5 kW, 0.94 s;
Muromachi Kikai, Tokyo, Japan) without anesthesia and then
analyzed the extracted brains (Sugiura et al, 2014). A report
provided by the American Veterinary Medical Association Recom-
mendations described that microwave irradiation is a humane
method for euthanizing small laboratory rodents, with the advan-
tages that unconsciousness is achieved in < 100 ms and a complete
loss of brain function in < 1 s.
ATP and ADP concentrations were measured using MRM (Mul-
tiple Reaction Monitoring) method by the LC-triple quadrupole
mass spectrometer (UHPLC: ACQUITY UPLC, Waters, Milford,
Massachusetts, USA; mass spectrometer: TSQ Vantage EMR, Ther-
moFisher), and using d5-AMP as an internal standard, at the
Support Unit for Bio-Material Analysis in RIKEN Center for Brain
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Science, Research Resource Division (RRD). Mouse samples (more
or less than mean  1.5SD in terms of ATP-to-ADP ratio) were
excluded (n = 1 for non-Tg group and n = 1 for Mpst -Tg group)
for analysis.
Analysis of mitochondrial cytochrome c oxidase activity
Mitochondrial cytochrome c oxidase activity was measured in non-
Tg (n = 6) and Mpst-Tg mice (n = 6) (both age of 6 weeks). Fresh
mitochondria were isolated from cerebral hemisphere by using
Mitochondria Isolation Kit for Tissue and Cultured Cells (Biochain,
Newark, CA, USA) and collected pellets were stored at 80°C until
use. At the timing of measurement, pellets were re-suspended in the
storage buffer [10 mM HEPES (pH 7.1–7.5), 250 mM sucrose, 1 mM
ATP, 80 lΜ ADP, 5 mM sodium succinate, and 2 mM K2HPO4].
The activity was determined by Cytochrome c Oxidase Assay Kit
(Sigma). The assay was performed using Ultrospec 3300 pro (GE
Healthcare). Results were represented in units per mg of protein
defined by Micro BCA Protein Assay Kit (ThermoFisher).
Analysis of spines
Primary culture of E16.5 hippocampal neurons from non-Tg and
Mpst-Tg mice were performed as previously described (Morikawa
et al, 2018). Briefly, dissociated hippocampal neurons were plated
on chambered coverslips coated with polyethyleneimine at 1 × 105
cells per well and cultured in a 5% CO2 atmosphere at 37°C. Cultured
hippocampal neurons at DIV 14–21 were transfected with an EGFP
expression vector using the calcium phosphate method for 2 days
before the observation. The dendritic spines were observed using a
confocal laser-scanning microscope (LSM780) equipped with an
Airyscan module (ZEISS). Data analyses were performed using
IMARIS (BITPLANE) software (Oxford Instruments, Abingdon, UK).
Protein S-palmitoylation assay
Protein S-palmitoylation in the brain was examined by the modified
ABE method (Forrester et al, 2011) with minor modifications. Brain
tissues (~20 mg wet weight) were lysed in 250 ll of lysis buffer
(50 mM Tris–HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 4% SDS,
2 mM PMSF) by sonication. The lysates were diluted with 250 ll of
Triton buffer (50 mM NaCl (pH 7.5), 150 mM NaCl, 5 mM EDTA,
0.2% Triton X-100, 2 mM PMSF) and then centrifuged for 10 min at
18,000 g and 15°C. The supernatants (~1.1 mg of protein) were
treated with 20 mM TCEP [Tris(2-carboxyethyl)phosphine, FUJI-
FILM Wako Pure Chemical Co., Osaka, Japan] for 30 min at room
temperature in a reaction volume of 1 ml to cleave disulfide
bonds. Next, the mixtures were treated with 40 mM NEM (N-ethyl
maleimide) for 2.5 h to block free thiol groups. For detection of
“global” S-palmitoylation, one-tenth of the mixture was stored as
“input” for Western blot analysis with HRP-labeled streptavidin
(GE Healthcare) under non-reducing conditions followed by non-
reducing SDS–PAGE. For detection of palmitoylation of specific
proteins, the remaining mixture after the ABE reaction was
extracted with 4 ml of methanol, 1 ml of chloroform, and 3 ml of
water, and the upper phase obtained after centrifugation at 5,800 g
for 10 min was removed. The pellet was rinsed twice with 10 ml
of methanol. The pellets were completely dissolved in 550 ll of
4% SDS buffer (4% SDS, 50 mM Tris–HCl (pH 7.5), 5 mM EDTA)
by sonication. To a 250-ll aliquot, 750 ll of HA(+) buffer [1 M
hydroxyamine (pH 7.5), 150 mM NaCl, 0.2% Triton X-100, 1 mM
biotin-HPDP (N-[6-(biotinamide)hexyl]-30-(20-pyridyldithio)pro-
pionamide; ThermoFisher), and 1 mM PMSF] or HA() buffer
(1 M Tris–HCl (pH 7.5), 150 mM NaCl, 0.2% Triton X-100, 1 mM
biotin-HPDP, and 1 mM PMSF). After incubation for an hour, the
mixture was extracted with 4 ml of methanol, 1 ml of chloroform,
and 3 ml of water, and the upper phase obtained after centrifuga-
tion at 5,800 g for 10 min was removed. The pellet was rinsed twice
with 10 ml of methanol. The pellet was dried and then dissolved in
170 ll of 2% SDS buffer [2% SDS, 50 mM Tris–HCl (pH 7.5),
150 mM NaCl, 5 mM EDTA, and 1 mM PMSF] by sonication. After
diluting with 10 volumes of 0.2% Triton buffer (0.2% Triton X-100,
50 mM Tris–HCl (pH 7.5), 5 mM EDTA), the biotinylated proteins
were captured with NeurAvidin agarose beads (ThermoFisher). The
complex was rinsed with wash buffer (0.2% Triton buffer supple-
mented with 0.1% SDS) three times. Biotinylated proteins were
released with 1.5× SDS sample buffer by boiling for 10 min and
subjected to Western blot analysis with an anti-PSD95 (Cell Signal-
ing, Danvers, MA, USA; cat. no. 3450), anti-Ras (Cell Signaling, cat.
no. 3965), anti-Cdc42 (Cell Signaling, cat. no. 2466), or anti-MBP
(Cell signaling, cat. no. 78896) antibody.
Genetic association study
The genetic association of MPST and CBS with schizophrenia was
evaluated by analyzing SNPs in 2,011 cases and 2,170 controls (Ban-
gel et al, 2015; Balan et al, 2017). MPST was examined using 4 tag
SNPs, and CBS was assessed with 7 tag SNPs and two promoter SNPs
(rs1788484 and rs2850144) (Appendix Table S15). The promoter
SNPs are described in the Tohoku Medical Megabank Organization of
Tohoku University (ToMMo) database of the Japanese population
(https://ijgvd.megabank.tohoku.ac.jp) (Nagasaki et al, 2015). The
SNPs were genotyped using TaqMan SNP genotyping assays (Applied
Biosystems) following the manufacturer’s instructions.
DNA methylation analysis
DNA methylation was performed using EpiTYPER on the MassARRAY
System platform (Agena Bioscience, San Diego, CA, USA) following
the manufacturer’s instructions. The sequence information of the
probes used for DNA methylation analysis and information on the
lengths of PCR products is shown in Appendix Table S17.
Poly-I:C model
Pregnant B6 mice received five consecutive intraperitoneal injec-
tions of poly-I:C (2 mg/ml, Sigma) dissolved in PBS (20 mg/kg) or
an equivalent volume of PBS at embryonic days 12, 13, 14, 15, and
16. At adulthood (13–14 weeks old), brains were dissected from
pups for analysis.
Data availability
RNA-seq data of Mpst-KO and Tg mice are available on NCBI
BioProject (https://www.ncbi.nlm.nih.gov/bioproject) accession
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numbers PRJDB8817 and PRJDB8818, respectively. Proteomics data
of mouse brain and lymphocytes are available on PeptideAtlas
(http://www.peptideatlas.org) Dataset Identifier PASS01452.
Expanded View for this article is available online.
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